UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of Earliest Event Reported): October 31, 2008

 

CardioNet, Inc.

(Exact name of registrant as specified in its charter)

 

 

Registrant’s telephone number, including area code: (610) 729-7000

 

Not Applicable

Former name or former address, if changed since last report

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

Item 7.01

Regulation FD Disclosure.

 

On October 31, 2008, CardioNet, Inc. (the “Company”) issued a press release announcing the establishment by the Centers for Medicare and Medicaid Services of reimbursement rates that cover the Company’s CardioNet System.  A copy of the press release is furnished herewith as Exhibit 99.1.

 

Item 9.01.	Financial Statements and Exhibits.
(d)	Exhibits.

 

Exhibit Number		Exhibit Title
99.1		Press Release, dated October 31, 2008.

 

2

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

	CardioNet, Inc.
November 4, 2008	By:		/s/ Martin P. Galvan
			Name: Martin P. Galvan
			Title: Chief Financial Officer

 

3

 

Exhibit Index

 

Exhibit Number		Exhibit Title
99.1		Press Release, dated October 31, 2008.

 

4